Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Cardiac Surgery Patients: Protocol Update for an Ongoing Phase 3, Double-Blind, Placebo-Controlled, Multicenter Study

Jerrold H Levy, Catrin Argyle, Cristina Solomon, Sigurd Knaub

Blood (2024) 144 (Supplement 1): 4026.1.

https://doi.org/10.1182/blood-2024-205111

Published: 2024

Journal Articles

Updated Protocol for the Phase 3, Randomized, Double-Blinded Lex-210 Study of Four-Factor Prothrombin Complex Concentrate in Patients with Acute Major Bleeding on Factor Xa Inhibitor Therapy

Ravindra Sarode, Stephan Maack, Cristina Solomon, Sigurd Knaub, Gita Pezeshki, Sam Schulman

Blood (2023) 142 (Supplement 1): 1256.

https://doi.org/10.1182/blood-2023-188990

Published: 2023

Journal Articles

Post-Marketing Observational Study of the Safety and Efficacy of Fibrinogen Concentrate in Congenital Fibrinogen Deficiency in Patients of All Ages

Flora Peyvandi, Gita Pezeshki, Cristina Solomon

Blood (2023) 142 (Supplement 1): 5514.

https://doi.org/10.1182/blood-2023-185849

Published: 2023

Journal Articles

Randomized, Active-Control Phase 3 Study of Four-Factor Prothrombin Complex Concentrate Versus Frozen Plasma in Bleeding Adult Cardiac Surgery Patients

Keyvan Karkouti, Jeannie Callum, Kenichi Tanaka, Deep Grewal, Cristina Solomon, Sigurd Knaub, Sylvia Werner, Jerrold H Levy

Blood (2023) 142 (Supplement 1): 5515.

https://doi.org/10.1182/blood-2023-186539

Published: 2023

Journal Articles

Atenativ, a Plasma-Derived Antithrombin Concentrate, Used in Patients with Congenital Antithrombin Deficiency Undergoing Surgery or Parturition: Study Description (NCT04918173)

Craig M. Kessler, Claudio Sandoval, Martina Jansen, Cristina Solomon, Sigurd Knaub, Michael D Tarantino

Blood (2022) 140 (Supplement 1): 8548–8549.

https://doi.org/10.1182/blood-2022-166246

Published: 2022

Journal Articles

A Phase 3, Randomized, Double-Blinded Study of Four-Factor Prothrombin Complex Concentrate in Patients with Acute Major Bleeding on Direct Oral Anticoagulant Therapy with Factor Xa Inhibitor: The Lex-210 Study

Ravi Sarode, Stephan Maack, Cristina Solomon, Sigurd Knaub, Sam Schulman

Blood (2021) 138 (Supplement 1): 3235.

https://doi.org/10.1182/blood-2021-152697

Published: 2021

Journal Articles

Prospective, Phase III Study of the Efficacy, Safety, and Pharmacokinetics of a Human Antithrombin III Concentrate in Congenital Antithrombin Deficiency during Surgery or Childbirth

Bruce A. Schwartz, Cristina Solomon, Sigurd Knaub, Craig M. Kessler

Blood (2021) 138 (Supplement 1): 3238.

https://doi.org/10.1182/blood-2021-152594

Published: 2021

Journal Articles

Efficacy and Safety of Human Fibrinogen Concentrate for the Treatment of Patients with Congenital Fibrinogen Deficiency: Combined Results of the FORMA-02 and FORMA-04 Clinical Trials

Claudia Djambas Khayat, MD BSc, Irina Kruzhkova, Cristina Solomon, Bruce A. Schwartz, PhD, Flora Peyvandi

Blood (2020) 136 (Supplement 1): 11–12.

https://doi.org/10.1182/blood-2020-141280

Published: 2020

Journal Articles

Safety and Efficacy of Fibrinogen Concentrate in Congenital Fibrinogen Deficiency: A Post-Marketing Observational Study

Bruce A. Schwartz, PhD, Flora Peyvandi, MD PhD, Cristina Solomon, Sigurd Knaub, Balazs Toth

Blood (2019) 134 (Supplement_1): 4971.

https://doi.org/10.1182/blood-2019-129891

Published: 2019

Journal Articles

Fibrinogen Concentrate Vs Cryoprecipitate in Pseudomyxoma Peritonei Surgery: Interim Results from a Prospective, Randomized, Controlled Phase 2 Study

Ashok Roy, Nigel Sargant, Savita Rangarajan, Sue Alves, John Bell, Sophia Stanford, Cristina Solomon, Irina Kruzhkova, Sigurd Knaub, Faheez Mohamed

Blood (2018) 132 (Supplement 1): 2549.

https://doi.org/10.1182/blood-2018-99-118145

Published: 2018

NARROW

Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Cardiac Surgery Patients: Protocol Update for an Ongoing Phase 3, Double-Blind, Placebo-Controlled, Multicenter Study

Updated Protocol for the Phase 3, Randomized, Double-Blinded Lex-210 Study of Four-Factor Prothrombin Complex Concentrate in Patients with Acute Major Bleeding on Factor Xa Inhibitor Therapy

Post-Marketing Observational Study of the Safety and Efficacy of Fibrinogen Concentrate in Congenital Fibrinogen Deficiency in Patients of All Ages

Randomized, Active-Control Phase 3 Study of Four-Factor Prothrombin Complex Concentrate Versus Frozen Plasma in Bleeding Adult Cardiac Surgery Patients

Atenativ, a Plasma-Derived Antithrombin Concentrate, Used in Patients with Congenital Antithrombin Deficiency Undergoing Surgery or Parturition: Study Description (NCT04918173)

A Phase 3, Randomized, Double-Blinded Study of Four-Factor Prothrombin Complex Concentrate in Patients with Acute Major Bleeding on Direct Oral Anticoagulant Therapy with Factor Xa Inhibitor: The Lex-210 Study

Prospective, Phase III Study of the Efficacy, Safety, and Pharmacokinetics of a Human Antithrombin III Concentrate in Congenital Antithrombin Deficiency during Surgery or Childbirth

Efficacy and Safety of Human Fibrinogen Concentrate for the Treatment of Patients with Congenital Fibrinogen Deficiency: Combined Results of the FORMA-02 and FORMA-04 Clinical Trials

Safety and Efficacy of Fibrinogen Concentrate in Congenital Fibrinogen Deficiency: A Post-Marketing Observational Study

Fibrinogen Concentrate Vs Cryoprecipitate in Pseudomyxoma Peritonei Surgery: Interim Results from a Prospective, Randomized, Controlled Phase 2 Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only